DLR vs LAB · P/E 158, $59.11B cap vs rev $174.4M
Digital Realty Trust Inc (DLR) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Digital Realty Trust Inc (DLR) is a reit - specialty company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
DLR does not have a complete income-statement cache yet.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
DLR currently screens at market cap $59.11B and trailing P/E 158.5. LAB currently screens at market cap $317.1M.
Not investment advice. Open the DLR and LAB stock pages for the full models.
Not investment advice.